"Logjam" and "bottleneck" became popular words as the industry entered what became called the "post-genomic era" (and grew into yet another oft-used phrase). But everybody was talking about data, not drugs and that, of course, became the problem. While there was plenty of information, not much in the way of new treatments was coming out of it quickly. (BioWorld Financial Watch)

If there's one thing for sure in biotechnology, it's uncertainty. And volatility, occasionally tilting into chaos. And hysteria, practically at the drop of a hat. (BioWorld Financial Watch)